A COMPARISON OF EPSTEIN‐BARR VIRUS‐SPECIFIC T‐CELL IMMUNITY IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS

DJ Moss(QIMR Berghofer Medical Research Institute), R. G. Kane(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), A. Klestov(Royal Brisbane and Women's Hospital)
Immunology and Cell Biology
October 1, 1983
10.1038/icb.1983.48
Cited by 13

Related Papers

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
|Nature|2012|695
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313